Clinical TrialsSearch results
Number of results: 416
Other
- MK-7684 with Pembrolizumab as a Coformulation (MK-7684A) Versus Pembrolizumab Monotherapy for PD-L1 Positive Metastatic NSCLC
- Untreated PD-L1 Positive Metastatic Non-Small Cell Lung Cancer
- Nohata Nijiro
- 2021-08-11
Recruiting
- The safety and efficacy of COVID-19 vaccines among lung transplant recipients
- lung transplant recipients
- Okada Yoshinori
- 2021-06-04
Other
- A Placebo-Controlled, Double-Blind, Phase II Physician-Initiated Trial of TM5614 in Patients with SARS-CoV-2 Pneumonia
- novel coronavirus (SARS-CoV-2) pneumonia
- Harigae Hideo
- 2021-05-28
Completed
- Efficacy and safety of apraglutide in SBS-IF
- short bowel syndrome and intestinal failure (SBS-IF)
- Kashiyama Akinori
- 2021-05-10
Completed
- Transvenous RFA for primary aldosteronism
- Left aldosterone producing adenoma.
- Takase Kei
- 2021-03-26
Recruiting
- An invetigation of radial incision and cutting for stenosis of small intestine using Flushknife long type.
- benign small bowel stenosis
- Moroi Rintaro
- 2021-03-01
Completed
- A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)
- Focal Segmental Glomerulosclerosis (FSGS)
- Kawai Norisuke
- 2020-12-16
Other
- A Phase III, Randomized, Multicenter, Double-blind, Placebo-controlled Study of Durvalumab for the Treatment of Stage II-III NSCLC Patients With Minimal Residual Disease Following Surgery and Curative Intent Therapy.
- Carcinoma, Non- Small Cell Lung
- Hibi Kazushige
- 2020-12-16
Other
- A0003 Eye Drops 0.55% Japan Phase III Study
- Cystinosis
- Ito Shuichi
- 2020-12-07
Other
- Invesigator-initiated phase 2 study to evaluate efficacy and safety of pyridoxamine in patients with premenstrual symdromes (PMS) and premenstrual dysphoric disorder (PMDD)
- Premenstrual Syndrome and Premenstrual Dysphoric Disorder
- Takeda Takashi
- 2020-11-10